H&H Group grants 13m share options to key personnel

On December 23, 2025, Health and Happiness (H&H) International Holdings Limited granted a total of 13,070,000 share options under its 2024 Share Scheme. These options, representing approximately 2% of the total number of shares in issue, were distributed among 41 eligible participants, including executive director Wang Yidong and four members of the CEO office. The exercise price for each share option is HK$13.54, determined as the higher of the closing price on the grant date or the average closing price over the preceding five business days.

The share options will vest over three years, with 30% vesting on April 1, 2027, another 30% on April 1, 2028, and the remaining 40% on April 1, 2029, subject to the fulfillment of specific performance targets. These targets encompass financial results, operational performance, business growth indicators, and individual grantee contributions. Once vested, the options are exercisable for 10 years from the grant date.

Noteworthy individual grants include Wang Yidong receiving 1,400,000 options, Li Fengting receiving 1,500,000 options, and Akash Bedi, Nicholas Russell Lamande Mann, and Zhang Qizhang each receiving 1,200,000 options. An additional 36 employees collectively received 6,570,000 options. Following this grant, 51,486,135 shares remain available for future grants under the 2024 Share Scheme mandate.